ChatDocto
Find a doctor
White scored tablet

EXJADE 250 mg

DEFERASIROX · dispersible tablets

B/28Oral use
See all pack prices
Strength250 mg
Therapeutic classDIVERS
ATC codeV03AC03

About this medicine

EXJADE 250 mg dispersible tablets is listed in Tunisia's medicine catalog under the active ingredient DEFERASIROX. This page brings together its recorded pack formats, prices and CNAM coverage information.

What is this medicine used for?

Review pending

A reviewed explanation of uses is not yet published for this medicine in this language. Ask a pharmacist for the leaflet for your exact product.

What side effects should I know about?

Review pending

A reviewed side-effect guide is not yet published for this medicine in this language. This does not mean that the medicine has no side effects. Read your product leaflet or ask a pharmacist.

Price by pack

Compare the recorded price for each exact pack. A catalog entry does not confirm pharmacy stock.

  • Pack · B/28

    28 units in this pack

    Price not recorded
    AMM No.
    10283252H
    CNAM reference amount
    CNAM status to be confirmed

    Price source: No verified price source is linked to this pack.

    Price effective date not provided

This reference amount is not a guaranteed refund or a personal out-of-pocket estimate. Your coverage conditions must be confirmed separately.

Medicine details

Dosage formdispersible tablets
Route of administrationOral use
LaboratoryNOVARTIS PHARMA SCHWEIZ AG
OriginOriginator
ScheduleA
ATC codeV03AC03 — Déférasirox
Therapeutic classDIVERS

Medicines with matching catalog characteristics

These entries match the recorded ingredient, strength, form and route. This does not establish that they can replace your medicine; confirm any change with a pharmacist.